1. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994-e1001.
https://doi.org/10.1542/peds.2014-3482
PMid:25733754
|
|
2. Cénat JM, Kokou-Kpolou CK, Blais-Rochette C, Morse C, Vandette MP, Dalexis RD, et al. Prevalence of ADHD among Black Youth Compared to White, Latino and Asian Youth: A Meta-Analysis. J Clin Child Adolesc Psychol. 2024;53(3):373-88.
https://doi.org/10.1080/15374416.2022.2051524
PMid:35427201
|
|
|
|
3. Do Austerman J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Cleve Clin J Med. 2015;82(3).
https://doi.org/10.3949/ccjm.82.s1.01
PMid:26555810
|
|
|
|
|
4. Prasad S, Kumminimana R. Attention-deficit/hyperactivity disorder: insights, advances and challenges in research and practice. 2025(2720-5371 (Electronic)).
|
|
|
|
5. Horstman LI, Koller D, Cabana-Domínguez J, Llonga N, Icick R, Vorspan F, et al. Polygenic risk scores reveal genetic underpinnings of comorbidity between substance use disorders and ADHD. 2026(1873-7862 (Electronic)).
https://doi.org/10.1016/j.euroneuro.2026.112799
PMid:41762898
|
|
|
|
6. Feng A, Zhi D, Fu Z, Yu S, Luo N, Calhoun V, et al. Genetic Etiology Link to Brain Function Underlying ADHD Symptoms and its Interaction with Sleep Disturbance: An ABCD Study. 2025(1995-8218 (Electronic)).
https://doi.org/10.1007/s12264-025-01349-9
PMid:39827443 PMCid:PMC12158910
|
|
|
|
7. Spillers Nj Fau - Talbot NC, Talbot Nc Fau - Luther PM, Luther Pm Fau - Ly GH, Ly Gh Fau - Roberts CJ, Roberts Cj Fau - Ahmadzadeh S, Ahmadzadeh S Fau - Shekoohi S, et al. Prenatal Acetaminophen Exposure and its Associated Risk for Attention Deficit Hyperactivity Disorder. 2024(2420-8124 (Electronic)).
https://doi.org/10.52965/001c.125267
PMid:39944717 PMCid:PMC11820131
|
|
|
|
8. Cortese S. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): what every clinician should know. European journal of paediatric neurology. 2012;16(5):422-33.
https://doi.org/10.1016/j.ejpn.2012.01.009
PMid:22306277
|
|
|
|
9. Kalenik A, Kardaś K, Rahnama A, Sirojć K, Wolańczyk T. Gut microbiota and probiotic therapy in ADHD: A review of current knowledge. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110277.
https://doi.org/10.1016/j.pnpbp.2021.110277
PMid:33561522
|
|
|
|
10. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257-68.
https://doi.org/10.1023/A:1022606501530
https://doi.org/10.1023/A:1022602400621
PMid:9700518
|
|
|
|
11. Pappas D. ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. Journal of psychoeducational assessment. 2006;24(2):172-8.
https://doi.org/10.1177/0734282905285792
|
|
|
|
12. Skott E, Yang LL, Stiernborg M, Söderström Å, Rȕegg J, Schalling M, et al. Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder-a double-blind randomized controlled trial. Brain, behavior, and immunity. 2020;89:9-19.
https://doi.org/10.1016/j.bbi.2020.05.056
PMid:32497779
|
|
|
|
13. Searight HR, Robertson K, Smith T, Perkins S, Searight BK. Complementary and alternative therapies for pediatric attention deficit hyperactivity disorder: a descriptive review. International Scholarly Research Notices. 2012;2012(1):804127.
https://doi.org/10.5402/2012/804127
PMid:23762770 PMCid:PMC3671686
|
|
|
|
14. Rianda D, Agustina R, Setiawan E, Manikam N. Effect of probiotic supplementation on cognitive function in children and adolescents: a systematic review of randomised trials. Beneficial microbes. 2019;10(8):873-82.
https://doi.org/10.3920/BM2019.0068
PMid:31965841
|
|
|
|
15. Lilly DM, Stillwell RH. PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS. Science. 1965;147(3659):747-8.
https://doi.org/10.1126/science.147.3659.747
PMid:14242024
|
|
|
|
|
16. RB P. Probiotics, the other half of the antibiotics story. Anim Nutr Health 1974;29:4-8.
|
|
|
|
17. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66(5):365-78.
https://doi.org/10.1111/j.1365-2672.1989.tb05105.x
PMid:2666378
|
|
|
|
18. Li YK, Li WR, Ren H, Xiao CL, Guo Z, Luo JA-O. Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations. 2025(1568-5608 (Electronic)).
https://doi.org/10.1007/s10787-025-02044-x
PMid:41236711
|
|
|
|
19. He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. 2019(1754-1611 (Print)).
https://doi.org/10.1186/s13036-019-0189-9
PMid:31297149 PMCid:PMC6599283
|
|
|
|
20. Liu X, Tong Y, Qin J, Zhao Y. Efficacy and safety of probiotic and synbiotic supplementation in metabolic syndrome: a systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2025;35(9):104100.
https://doi.org/10.1016/j.numecd.2025.104100
PMid:40348630
|
|
|
|
|
21. Leta VA-O, Zinzalias P, Batzu LA-O, Mandal G, Staunton J, Jernstedt F, et al. Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial. 2025(1531-8257 (Electronic)).
|
|
|
|
|
22. Zandifar AA-O, Badrfam RA-O, Mohammaditabar MA-O, Kargar B, Goodarzi S, Hajialigol AA-O, et al. The Effect of Prebiotics and Probiotics on Levels of Depression, Anxiety, and Cognitive Function: A Meta-Analysis of Randomized Clinical Trials
|
|
|
|
|
2025(2162-3279 (Electronic)).
|
|
|
|
23. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-12.
https://doi.org/10.1093/jn/125.6.1401
PMid:7782892
|
|
|
|
24. Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17(11):687-701.
https://doi.org/10.1038/s41575-020-0344-2
PMid:32826966 PMCid:PMC7581511
|
|
|
|
25. LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microbial cell factories. 2017;16(1):79.
https://doi.org/10.1186/s12934-017-0691-z
PMid:28482838 PMCid:PMC5423028
|
|
|
|
26. Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Current opinion in gastroenterology. 2015;31(2):153-8.
https://doi.org/10.1097/MOG.0000000000000151
PMid:25594887
|
|
|
|
27. Ng QX, Loke W, Venkatanarayanan N, Lim DY, Soh AYS, Yeo WS. A systematic review of the role of prebiotics and probiotics in autism spectrum disorders. Medicina. 2019;55(5):129.
https://doi.org/10.3390/medicina55050129
PMid:31083360 PMCid:PMC6571640
|
|
|
|
28. Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric research. 2015;77(6):823-8.
https://doi.org/10.1038/pr.2015.51
PMid:25760553
|
|
|
|
29. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biological psychiatry. 2013;74(10):720-6.
https://doi.org/10.1016/j.biopsych.2013.05.001
PMid:23759244 PMCid:PMC11788897
|
|
|
|
30. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, Nieves Jr C, Khouri L, et al. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition. 2015;113(3):426-34.
https://doi.org/10.1017/S0007114514003997
PMid:25604727
|
|
|
|
31. Hara T, Mihara T, Ishibashi M, Kumagai T, Joh T. Heat-killed Lactobacillus casei subsp. casei 327 promotes colonic serotonin synthesis in mice. Journal of Functional Foods. 2018;47:585-9.
https://doi.org/10.1016/j.jff.2018.05.050
|
|
|
|
32. Nimgampalle M, Kuna Y. Anti-Alzheimer properties of probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's disease induced albino rats. Journal of clinical and diagnostic research: JCDR. 2017;11(8):KC01.
https://doi.org/10.7860/JCDR/2017/26106.10428
PMid:28969160 PMCid:PMC5620801
|
|
|
|
33. Sakurai T, Odamaki T, Xiao J-z. Production of indole-3-lactic acid by bifidobacterium strains isolated fromhuman infants. Microorganisms. 2019;7(9):340.
https://doi.org/10.3390/microorganisms7090340
PMid:31514325 PMCid:PMC6780619
|
|
|
|
34. Vasiliu O. The current state of research for psychobiotics use in the management of psychiatric disorders-A systematic literature review. Frontiers in Psychiatry. 2023;14:1074736.
https://doi.org/10.3389/fpsyt.2023.1074736
PMid:36911130 PMCid:PMC9996157
|
|
|
|
35. Cheng H-W, Jiang S, Hu J. Gut-brain axis: Probiotic, Bacillus subtilis, prevents aggression via the modification of the central serotonergic system. Oral health by using probiotic products: IntechOpen; 2019.
https://doi.org/10.5772/intechopen.86775
|
|
|
|
36. Reis DJ, Ilardi SS, Punt SE. The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. PloS one. 2018;13(6):e0199041.
https://doi.org/10.1371/journal.pone.0199041
PMid:29924822 PMCid:PMC6010276
|
|
|
|
37. Takahashi K, Nakagawasai O, Nemoto W, Odaira T, Sakuma W, Onogi H, et al. Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain-gut axis. Journal of neuroinflammation. 2019;16(1):201.
https://doi.org/10.1186/s12974-019-1580-7
PMid:31672153 PMCid:PMC6822456
|
|
|
|
38. Yang LL, Stiernborg M, Skott E, Xu J, Wu Y, Landberg R, et al. Effects of a synbiotic on plasma immune activity markers and short-chain fatty acids in children and adults with ADHD-a randomized controlled trial. Nutrients. 2023;15(5):1293.
https://doi.org/10.3390/nu15051293
PMid:36904292 PMCid:PMC10004766
|
|
|
|
39. Arteaga-Henríquez G, Ramos-Sayalero C, Ibañez-Jimenez P, Rosales-Ortiz SK, Kilencz T, Schiweck C, et al. Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled,"basket" trial. Brain, Behavior, and Immunity. 2024;120:360-71.
https://doi.org/10.1016/j.bbi.2024.06.012
PMid:38885746
|
|
|
|
40. Allahyari P, Abbas Torki S, Aminnezhad Kavkani B, Mahmoudi Z, Mousavi Hoseini MS, Moradi M, et al. A systematic review of the beneficial effects of prebiotics, probiotics, and synbiotics on ADHD. Neuropsychopharmacology Reports. 2024;44(2):300-7.
https://doi.org/10.1002/npr2.12437
PMid:38623929 PMCid:PMC11144606
|
|
|
|
41. Liang S-C, Sun C-K, Chang C-H, Cheng Y-S, Tzang R-F, Chiu H-J, et al. Therapeutic efficacy of probiotics for symptoms of attention-deficit hyperactivity disorder in children and adolescents: meta-analysis. BJPsych Open. 2024;10(1):e36.
https://doi.org/10.1192/bjo.2023.645
PMid:38268113 PMCid:PMC10897698
|
|
|
|
42. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma G. Ítems de referencia para publicar revisiones sistemáticas y metaanálisis: la Declaración PRISMA. Revista Española de Nutrición Humana y Dietética. 2014;18(3):172-81.
https://doi.org/10.14306/renhyd.18.3.114
|
|
|
|
43. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. bmj. 2011;343.
https://doi.org/10.1136/bmj.d5928
PMid:22008217
|
|
|
|
44. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. Journal of clinical epidemiology. 2011;64(12):1283-93.
https://doi.org/10.1016/j.jclinepi.2011.01.012
PMid:21839614 PMCid:PMC7009893
|
|
|
|
45. Gordon H, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. Rating quality of evidence and strength of recommendations: GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 2008;336(7650):924-6.
https://doi.org/10.1136/bmj.39489.470347.AD
PMid:18436948
|
|
|
|
46. Elhossiny RM, Elshahawy HH, Mohamed HM, Abdelmageed RI. Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial. BMC psychiatry. 2023;23(1):823.
https://doi.org/10.1186/s12888-023-05324-4
PMid:37946220 PMCid:PMC10636814
|
|
|
|
47. Ghanaatgar M, Taherzadeh S, Ariyanfar S, Razeghi Jahromi S, Martami F, Mahmoudi Gharaei J, et al. Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial. Nutrition & Food Science. 2023;53(1):19-34.
https://doi.org/10.1108/NFS-12-2021-0388
|
|
|
|
48. Kumperscak HG, Gricar A, Ülen I, Micetic-Turk D. A pilot randomized control trial with the probiotic strain Lactobacillus rhamnosus GG (LGG) in ADHD: children and adolescents report better health-related quality of life. Frontiers in psychiatry. 2020;11:181.
https://doi.org/10.3389/fpsyt.2020.00181
PMid:32256407 PMCid:PMC7092625
|
|
|
|
49. Sepehrmanesh Z, Shahzeidi A, Mansournia MA, Ghaderi A, Ahmadvand A. Clinical and metabolic reaction to probiotic supplement in children suffering attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled experiment. International Archives of Health Sciences. 2021;8(2):90-6.
https://doi.org/10.4103/iahs.iahs_112_20
|
|
|
|
50. Nahidi M, Soleimanpour S, Emadzadeh M. Probiotics as a promising therapy in improvement of symptoms in children with ADHD: A systematic review. Journal of Attention Disorders. 2024;28(8):1163-72.
https://doi.org/10.1177/10870547241228828
PMid:38369739
|
|
|
|
51. Liu Y-W, Liong MT, Chung Y-CE, Huang H-Y, Peng W-S, Cheng Y-F, et al. Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: a randomized, double-blind, placebo-controlled trial. Nutrients. 2019;11(4):820.
https://doi.org/10.3390/nu11040820
PMid:30979038 PMCid:PMC6521002
|
|
|
|
52. Wu C-C, Wong L-C, Hsu C-J, Yang C-W, Tsai Y-C, Cheng F-S, et al. Randomized controlled trial of probiotic PS128 in children with Tourette syndrome. Nutrients. 2021;13(11):3698.
https://doi.org/10.3390/nu13113698
PMid:34835954 PMCid:PMC8619307
|
|
|
|
53. Noudoost B, Moore T. The role of neuromodulators in selective attention. Trends in cognitive sciences. 2011;15(12):585-91.
https://doi.org/10.1016/j.tics.2011.10.006
PMid:22074811 PMCid:PMC3351278
|
|
|
|
54. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012;13(10):701-12.
https://doi.org/10.1038/nrn3346
PMid:22968153
|
|
|
|
55. Ligezka AN, Sonmez AI, Corral-Frias MP, Golebiowski R, Lynch B, Croarkin PE, et al. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021;108:110187.
https://doi.org/10.1016/j.pnpbp.2020.110187
PMid:33271210 PMCid:PMC8138744
|
|
|
|
56. Zhang S, Wu Z, Zhang S, Ru YA-OX, Wang Q, Tong H, et al. The intricate microbial-gut-brain axis in Alzheimer's disease: a review of microbiota-targeted strategies. 2025(2042-650X (Electronic)).
https://doi.org/10.1039/D5FO03139G
PMid:41085348
|
|
|
|
57. Geng ZH, Zhu Y, Li QL, Zhao C, Zhou PH. Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders. Front Aging Neurosci. 2022;14:810483.
https://doi.org/10.3389/fnagi.2022.810483
PMid:35517052 PMCid:PMC9063565
|
|
|
|
58. Furness JB, Stebbing MJ. The first brain: Species comparisons and evolutionary implications for the enteric and central nervous systems. Neurogastroenterol Motil. 2018;30(2).
https://doi.org/10.1111/nmo.13234
PMid:29024273
|
|
|
|
59. Yuan C, He Y, Xie K, Feng L, Gao S, Cai L. Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases. Front Cell Infect Microbiol. 2023;13:1282431.
https://doi.org/10.3389/fcimb.2023.1282431
PMid:37868345 PMCid:PMC10585369
|
|
|
|
60. Pellegrini C, Antonioli L, Lopez-Castejon G, Blandizzi C, Fornai M. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. Front Immunol. 2017;8:36.
https://doi.org/10.3389/fimmu.2017.00036
PMid:28179906 PMCid:PMC5263152
|
|
|
|
61. Aarts E, Ederveen TH, Naaijen J, Zwiers MP, Boekhorst J, Timmerman HM, et al. Gut microbiome in ADHD and its relation to neural reward anticipation. PloS one. 2017;12(9):e0183509.
https://doi.org/10.1371/journal.pone.0183509
PMid:28863139 PMCid:PMC5581161
|
|
|
|
62. Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599-609. e3.
https://doi.org/10.1053/j.gastro.2011.04.052
PMid:21683077 PMCid:PMC11788897
|
|
|
|
63. Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Frontiers in immunology. 2021;12:578386.
https://doi.org/10.3389/fimmu.2021.578386
PMid:33717063 PMCid:PMC7953067
|
|
|
|
64. Li X, Hu S, Yin J, Peng X, King L, Li L, et al. Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial. Gut Microbes. 2023;15(2):2247025.
https://doi.org/10.1080/19490976.2023.2247025
PMid:37614109 PMCid:PMC10453972
|
|
|
|
65. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences. 2011;108(38):16050-5.
https://doi.org/10.1073/pnas.1102999108
PMid:21876150
|
|
|
|
66. Cenit MC, Nuevo IC, Codoñer-Franch P, Dinan TG, Sanz Y. Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition. European child & adolescent psychiatry. 2017;26(9):1081-92.
https://doi.org/10.1007/s00787-017-0969-z
PMid:28289903
|
|
|
|
67. Corominas-Roso M, Ramos-Quiroga JA, Ribases M, Sanchez-Mora C, Palomar G, Valero S, et al. Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. International Journal of Neuropsychopharmacology. 2013;16(6):1267-75.
https://doi.org/10.1017/S1461145712001629
PMid:23363778
|
|
|
|
68. Dinan TG, Cryan JF. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Current Opinion in Clinical Nutrition & Metabolic Care. 2015;18(6):552-8.
https://doi.org/10.1097/MCO.0000000000000221
PMid:26372511
|
|
|
|
69. Mennigen R, Bruewer M. Effect of probiotics on intestinal barrier function. Annals of the New York Academy of Sciences. 2009;1165(1):183-9.
https://doi.org/10.1111/j.1749-6632.2009.04059.x
PMid:19538305
|
|
|
|
70. Tsai S-J. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Medical hypotheses. 2007;68(4):896-9.
https://doi.org/10.1016/j.mehy.2006.06.025
PMid:16919891
|
|
|
|
71. Chen X, Chen C, Ma C, Kang W, Wu J, Fu X. Dendrobium officinale polysaccharide attenuates type 2 diabetes in mice model by modulating gut microbiota and alleviating intestinal mucosal barrier damage. Food Science and Human Wellness. 2025;14(1):9250007.
https://doi.org/10.26599/FSHW.2024.9250007
|
|
|
|
72. Su M, Tang T, Tang W, Long Y, Wang L, Liu M. Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. 2023(1664-3224 (Electronic)).
https://doi.org/10.3389/fimmu.2023.1243834
PMid:37638043 PMCid:PMC10450032
|
|
|
|
73. Zhang Y, Deng J, Chen T, Liu S, Tang Y, Zhao JR, et al. Formononetin alleviates no reflow after myocardial ischemia-reperfusion via modulation of gut microbiota to inhibit inflammation. 2024(1879-0631 (Electronic)).
https://doi.org/10.1016/j.lfs.2024.123110
PMid:39374772
|
|
|
|
74. Wu M, Shu H, Wang M, Xu Y, Zhang Y, Jiang X, et al. Protective effects of Angelica sinensis polysaccharide on chemotherapy-injured rats with premature ovarian insufficiency and its impact on gut microbiota. 2025(1663-9812 (Print)).
https://doi.org/10.3389/fphar.2025.1685281
PMid:41347161 PMCid:PMC12672475
|
|
|
|
75. Song C, Wei Q, Shen H, Zhang X, Pan D, Zhang Z, et al. Therapeutic potential of Glycyrrhiza polysaccharides in pseudorabies virus infection: immune modulation, antioxidant activity, and gut microbiota restoration. 2025(2297-1769 (Print)).
https://doi.org/10.3389/fvets.2025.1679013
PMid:41180235 PMCid:PMC12575151
|
|
